using targeted therapies to optimize transplant outcomes in aml
Published 1 year ago • 72 plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
2:41
an overview of the latest advances in hematology
-
16:50
nanotechnology in cancer research | jessica winter | tedxcolumbus
-
12:17
avoiding the immune attack: daniel anderson, ph.d. at tedxdelmar
-
9:22
nanomedicines -- the way of the future? | emmanuel ho | tedxumanitoba
-
3:17
pet imaging to predict treatment outcomes: follow-up from the echelon-2 trial
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
15:03
targeted therapy for liver cancer assisted by nanotechnology | taeghwan hyeon | tedxkfas
-
14:43
current research into post-allosct maintenance therapy in aml
-
1:03
the importance of the mdt in managing transplant survivors
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
1:03
insights into the cartitude-6 trial: rationale and design
-
0:45
difference between quality of life & patient-reported outcomes
-
1:34
the evolving role of transplantation
-
5:18
upfront treatment in transplant candidates
-
1:58
asct in the outpatient setting
-
2:10
key highlights from ebmt 2023
-
1:56
advances in off-the-shelf third-party t-cells for the treatment of infectious diseases post-bmt